Cutaneous Leishmaniasis Terminated Phase 3 Trials for Nitric Oxide (DB00435)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00317629Controlled Nitric Oxide Releasing Patch Versus Meglumine Antimoniate in the Treatment of Cutaneous LeishmaniasisTreatment